Sionna Therapeutics, Inc. <SION.O>: Wedbush cuts to neutral from outperform; cuts target price to $5 from $53
SION•Related News
Moody’s upgrades Teva to investment-grade Baa3 rating
TEVA•
Collective Mining begins trading on Nasdaq after NYSE American delisting
CNL•
Joby Aviation to acquire defense tech firm Resonant Sciences for about $500 million
JOBY•
Kalaris net loss widens to $11.52 million in Q2 FY26
KLRS•
Axsome Therapeutics, Inc. <AXSM.O>: Morgan Stanley raises target price to $251 from $242
AXSM•